Search Results - "Soon YY"

Research productivity of RANZCR radiation oncology trainees from 2014 to 2023.

Authors: Quinn EJ Roos D James M et al.

Source: Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2024 Oct; Vol. 68 (7), pp. 828-834. Date of Electronic Publication: 2024 Sep 20.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101469340 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1754-9485 (Electronic) Linking ISSN: 17549477 NLM ISO Abbreviation: J Med Imaging Radiat Oncol Subsets: MEDLINE

Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials.

Authors: Lee CK Lefresne S Soon YY et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 May; Vol. 21 (5), pp. 103549. Date of Electronic Publication: 2026 Jan 12.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Restricted mean survival time approach versus time-varying coefficient Cox model for quantifying treatment effect when hazards are non-proportional.

Authors: Gu T Chen Z Soon YY et al.

Source: BMC medical research methodology [BMC Med Res Methodol] 2025 Jul 01; Vol. 25 (1), pp. 164. Date of Electronic Publication: 2025 Jul 01.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288 (Electronic) Linking ISSN: 14712288 NLM ISO Abbreviation: BMC Med Res Methodol Subsets: MEDLINE

Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.

Authors: Zhou, Hongmei Zhang, Min Jin, Yi et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-12. 12p.

Case-based comparison of flow cytometry and immunofixation electrophoresis in IgD triclonal gammopathy multiple myeloma: a rare case report.

Authors: TURKES, Gulsum Feyza DEVRIM, Erdinc DALVA, Klara et al.

Source: Marmara Medical Journal. May2026, Vol. 39 Issue 2, p170-174. 5p.

The clinical utility of endobronchial ultrasound-guided transbronchial needle aspiration: A single-center experience from the Middle East.

Authors: Bennji, Sami M. Jayakrishnan, B. Al-Hashami, Zamzam et al.

Source: Annals of Thoracic Medicine. Apr-Jun2026, Vol. 21 Issue 2, p103-109. 7p.

Quality Indicators and Benchmarks for Radiotherapy in Lung Cancer: A Modified Delphi Approach.

Authors: Chiew KL Donnelly C Harden SV et al.

Source: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2025 Aug; Vol. 44, pp. 103886. Date of Electronic Publication: 2025 May 30.

Publication Type: Journal Article

Journal Info: Publisher: W.B. Saunders Country of Publication: England NLM ID: 9002902 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2981 (Electronic) Linking ISSN: 09366555 NLM ISO Abbreviation: Clin Oncol (R Coll Radiol) Subsets: MEDLINE

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Authors: de Jong, A. M. van der Boog, A. T. J. Post, C. C. B. et al.

Source: PLoS ONE. 2/9/2026, Vol. 21 Issue 2, p1-20. 20p.

Response to Osimertinib Observed in Meningeal-Metastatic NSCLC with EGFR A763V Mutation: A Case Report and Literature Review.

Authors: Xu, Yu Li, Jie

Source: OncoTargets & Therapy. Jan2026, Vol. 19, p1-10. 10p.

ASO Author Reflection: The TME-Related Gene AIF1 Signature Predicts Esophageal Carcinoma Prognosis.

Authors: Xu X Wang D Li N et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2022 May; Vol. 29 (5), pp. 2941. Date of Electronic Publication: 2022 Feb 15.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

TCF3::BEND2 in paediatric supratentorial tumour with carcinoma‐like epithelial features classifying as MN1‐altered astroblastoma by DNA methylation profiling.

Authors: Nakano, Yoshiko Nobusawa, Sumihito Sato‐Otsubo, Aiko et al.

Source: Neuropathology & Applied Neurobiology. Oct2024, Vol. 50 Issue 5, p1-5. 5p.

Efficacy and safety of anti-CD38 monoclonal antibodies in patients with newly diagnosed multiple myeloma: an updated systematic review and meta-analysis based on randomized controlled trials.

Authors: Lin, Zujie Dong, Ruijun Zhang, Wenxiang et al.

Source: Leukemia & Lymphoma. Oct2025, Vol. 66 Issue 10, p1839-1849. 11p.

Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial.

Authors: Tan, Chao Li, Yuyi Chen, Xiaoyu et al.

Source: BMC Cancer. 4/7/2025, Vol. 25 Issue 1, p1-10. 10p.

Challenges of estimating treatment effects after a positive interim analysis.

Authors: Soon YY Marschner IC Schou M et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 209, pp. 114230. Date of Electronic Publication: 2024 Jul 19.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Author index.

Source: Cephalalgia. Dec2005, Vol. 25 Issue 12, p1206-1212. 7p.

Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.

Authors: Liu, Ting Dong, Di Zhao, Xun et al.

Source: BMC Medicine. 11/27/2023, Vol. 21 Issue 1, p1-13. 13p.

Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study.

Authors: Zhang, Quxia Huang, Wanfang Chen, Xinlan et al.

Source: BMC Cancer. 8/1/2025, Vol. 25 Issue 1, p1-9. 9p.

Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study.

Authors: Zhang, Xue Dai, Xin Liu, Aina et al.

Source: BMC Medicine. 12/18/2024, Vol. 22 Issue 1, p1-18. 18p.

Impact of monitor unit optimization in volumetric modulated arc therapy planning for nasopharyngeal carcinoma.

Authors: Zeng, Huaqu Li, Zhen Chen, Zongyou et al.

Source: PLoS ONE. 6/25/2025, Vol. 20 Issue 6, p1-15. 15p.

Optimal daratumumab-based regimen for patients with newly diagnosed and previously untreated multiple myeloma: systematic review and component network meta-analysis.

Authors: Huang, Xiaohua Zhou, Jia Qian, Yuxiao et al.

Source: Systematic Reviews. 5/16/2025, Vol. 14 Issue 1, p1-13. 13p.